• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioasis Technologies Inc (OP: BIOAF )

    0.0001 UNCHANGED
    Streaming Delayed Price Updated: 9:31 AM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 0.0001
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0001
    Today's Range 0.0001 - 0.0001
    52wk Range 0.0001 - 0.0130
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bioasis Provides Corporate Update and Announces Suspension of Operations
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Provides Update on Business Operations
    From Bioasis Technologies Inc.
    Via GlobeNewswire

    Performance

    YTD
    -97.92%
    -97.92%
    1 Month
    N/A
    N/A
    3 Month
    N/A
    N/A
    6 Month
    N/A
    N/A
    1 Year
    -96.77%
    -96.77%

    More News

    Read More
    Bioasis Announces AGM Results and Provides Update on Financial Position
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Announces Shareholder Webinar
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022
    From Bioasis Technologies Inc.
    Via GlobeNewswire
    The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
    Via Benzinga
    Bioasis Technologies’ xB3 Platform Unlocks Revolutionary Neurological Disease Treatments
    Via Get News
    Bioasis Technologies Breaks through Blood-Brain Barrier with xB3 platform, Revolutionizing Neurological Disease Treatment
    Via Get News
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.